BTIG Research initiated coverage on Veeva Systems with a new price target
$VEEV
Computer Software: Prepackaged Software
Technology
BTIG Research initiated coverage of Veeva Systems with a rating of Buy and set a new price target of $240.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/29/2025 | $270.00 → $300.00 | Buy | Needham |
| 1/23/2025 | $261.00 → $200.00 | Buy → Sell | Goldman |
| 12/20/2024 | $280.00 | Overweight | Stephens |
| 12/4/2024 | $275.00 | Outperform | Mizuho |
| 11/19/2024 | $235.00 | Sector Perform | Scotiabank |
| 10/8/2024 | $286.00 | Outperform | Exane BNP Paribas |
| 8/27/2024 | $256.00 → $273.00 | Buy | Citigroup |
| 7/9/2024 | $240.00 | Buy | BTIG Research |
Needham reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $300.00 from $270.00 previously
Goldman downgraded Veeva Systems from Buy to Sell and set a new price target of $200.00 from $261.00 previously
Stephens initiated coverage of Veeva Systems with a rating of Overweight and set a new price target of $280.00
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
AWS compute, database, and global infrastructure support Veeva's industry cloud for life sciences Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ:AMZN), and Veeva Systems (NYSE:VEEV), a leading provider of software, data, and business consulting for the life sciences industry, today announced an expansion of their long-standing collaboration. Veeva is using AWS as the cloud infrastructure for its Veeva Vault applications, including Veeva Vault CRM Suite. More than 50 Veeva Vault applications and specialized data offerings such as Veeva Compass and Veeva CRM Pulse now use the proven security, performance, and scalability of AWS. Building on the long-standing AWS and
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif., June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clinical Platform applications to simplify and streamline medical device and diagnostics studies. With increasing regulatory requirements and evolving markets, medtech companies are moving away from siloed legacy solutions to modern connected applications from Veeva MedTech.
Industry focused on automation, connectivity, and reporting for proactive quality management PLEASANTON, Calif., June 9, 2025 /PRNewswire/ -- The 2025 Veeva MedTech Postmarket Quality Benchmark Report reveals that 88% of the medtech companies surveyed are advancing postmarket quality management within the next three years to improve compliance and drive innovation. This signals a shift toward modernization to reduce risk and foster a stronger culture of quality across the product lifecycle. While the move to more scalable solutions is planned or underway for most, 68% of medte
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
144 - VEEVA SYSTEMS INC (0001393052) (Subject)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)